Ocugen
PA - MalvernBiotechnology
Focus: Ocugen is a clinical-stage biotechnology company focused on sight-threatening diseases in ophthalmology and infectious diseases, based in Malvern, PA. The company operates with a lean pipeline of gene therapies and small-molecule candidates across retinal dystrophies, ocular inflammation, and infectious indications.
Profile data last refreshed 13h ago · AI intelligence enriched 3d ago
Open Jobs
7-3 this month
Stable — net -3 jobs in 30d
53 added, 56 removed. Backfill posture.
Should You Work at Ocugen?
AI assessmentOcugen is a pre-revenue biotech with clinically differentiated programs in rare ophthalmology but constrained hiring and opaque financial health; best suited for early-career scientists willing to accept execution risk for meaningful therapeutic impact.
Why Work Here
- Early-stage pipeline with 13 active trials across Phase 1–3, including two Phase 3 programs (Brimonidine Tartrate for GVHD and OCU400-301 for Retinitis Pigmentosa) offering near-term value inflection catalysts.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
OCU400
Retinitis PigmentosaClinical Trials (1)
NCT06574997Expanded Access Program for RP in Adults
N/AHelp build intelligence for Ocugen
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.